Assay Detail
Functional
CHEMBL5227185
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
9
Total Activities
9
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | MDA-MB-231 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 9 | 5.54 | 6.52 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL2180182 | — | — | 1 | 6.52 |
| CHEMBL1454946 | FLUBENDAZOLE | 2.0 | 1 | 6.30 |
| CHEMBL41 | FLUOXETINE | 4.0 | 1 | 6.30 |
| CHEMBL1448 | NICLOSAMIDE | 4.0 | 1 | 6.20 |
| CHEMBL5277941 | — | — | 1 | 5.30 |
| CHEMBL5286755 | — | — | 1 | 5.10 |
| CHEMBL5275643 | — | — | 1 | 4.92 |
| CHEMBL136356 | HELENINE | — | 1 | 4.82 |
| CHEMBL465208 | SALIDROSIDE | — | 1 | 4.40 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL2180182 | — | IC50 | = | 300.0 | nM | 6.52 |
| CHEMBL1454946 | FLUBENDAZOLE | IC50 | = | 500.0 | nM | 6.30 |
| CHEMBL41 | FLUOXETINE | IC50 | = | 500.0 | nM | 6.30 |
| CHEMBL1448 | NICLOSAMIDE | IC50 | = | 625.0 | nM | 6.20 |
| CHEMBL5277941 | — | IC50 | = | 5000.0 | nM | 5.30 |
| CHEMBL5286755 | — | IC50 | = | 7910.0 | nM | 5.10 |
| CHEMBL5275643 | — | IC50 | = | 12140.0 | nM | 4.92 |
| CHEMBL136356 | HELENINE | IC50 | = | 15000.0 | nM | 4.82 |
| CHEMBL465208 | SALIDROSIDE | IC50 | = | 40000.0 | nM | 4.40 |